公开(公告)号：EP1267866A2

公开(公告)日：2003-01-02

申请号：EP01966751.8

申请日：2001-04-09

Applicant: Arakis Limited

Inventor： BANNISTER, Robin Mark,Arakis Ltd. ,  RICHARDS, Andrew John McGlashan ,  GILBERT, Julian Clive,Arakis Ltd. ,  MORTON, David A., V.,Vectura Limited ,  STANIFORTH, JohnVectura Limited

IPC: A61K31/40

CPC classification number: A61K9/0075 ,  A61K9/145 ,  A61K31/00 ,  A61K31/40 ,  A61K31/46 ,  A61K45/06 ,  Y10S514/826 ,  Y10S514/851 ,  A61K2300/00

Abstract: A pharmaceutical composition for pulmonary delivery comprises glycopyrrolate in a controlled release formulation, wherein, on administration, the glycopyrrolate exerts its pharmacological effect over a period greater than 12 hours.